Browsing by Author Ascanio, Meritxell

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
Jan-2021A discrete choice experiment to understand preferences of patients with type 2 diabetes treated with injectable non-insulinic agentsDarbà, Josep; Ascanio, Meritxell
Apr-2019Admissions and Cost of Hospitalisation of Phenylketonuria: Spanish Claims Database AnalysisDarbà, Josep; Ascanio, Meritxell
Sep-2018Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in SpainDarbà, Josep; Ascanio, Meritxell
Nov-2017Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus - from the Spanish National Health System perspectiveMezquita-Raya, Pedro; Darbà, Josep; Ascanio, Meritxell; Ramírez de Arellano, Antonio
20-Dec-2019Cost-effectiveness of insulin degludec versus insulin glargine U100 in patients with type 1 and type 2 diabetes in Portugal: evidence from SWITCH 1&2 trialsDarbà, Josep; Ascanio, Meritxell; Carvalho, Davide; Conde, Vasco; Pedersen, Kasper S.
11-Dec-2020Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in SpainRomero Gómez, Manuel 1967-; Kachru, Nandita; Ascanio, Meritxell; Darbà, Josep; Shreay, Sanatan
23-Apr-2021Economic Evaluation of the Use of FeNO for the Diagnosis and Management of Asthma Patients in Primary Care in SwedenDarbà, Josep; Ascanio, Meritxell; Syk, Jörgen; Alving, Kjell
1-Mar-2021Economic impact of dry eye disease in Spain: A multicentre retrospective insurance claims database analysisDarbà, Josep; Ascanio, Meritxell
Mar-2019Enzymatic replacement therapy for lysosomal storage disorders: Drug evaluations review in SpainDarbà, Josep; Ascanio, Meritxell
Dec-2020Epidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain: a claims database analysisMarsà, Alícia; Ascanio, Meritxell; Diaz-García, Javier; Darbà, Josep
Nov-2022Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation ModelEleftheriou, Androulla; Antoniou, Eleni; Darbà, Josep; Ascanio, Meritxell; Angastiniotis, Michael; Farmakis, Dimitrios
7-Apr-2021Hyperkalaemia management and related costs in chronic kidney disease patients with comorbidities in SpainOlry de Labry Lima, Antonio; Díaz Castro, Óscar; Romero Requena, Jorge M.; García Díaz-Guerra, M. Reyes; Arroyo Pineda, Virginia; Hija Díaz, Belén de la; Ascanio, Meritxell; Darbà, Josep; Cruzado, Josep M.
27-Feb-2023Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysisDarbà, Josep; Ascanio, Meritxell
Oct-2019The current performance-linked and risk sharing agreement scene in the Spanish region of CataloniaDarbà, Josep; Ascanio, Meritxell
2019Therapy for Gastroenteropancreatic Neuroendocrine Tumors: drug evaluation reports review in SpainDarbà, Josep; Ascanio, Meritxell